3.30Open3.30Pre Close0 Volume10 Open Interest1.00Strike Price0.00Turnover1013.35%IV-10.04%PremiumJul 19, 2024Expiry Date3.78Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9699Delta0.0115Gamma1.23Leverage Ratio-0.0364Theta0.0001Rho1.19Eff Leverage0.0004Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet